337 related articles for article (PubMed ID: 16043681)
1. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation.
Escalante A; Haas RW; del Rincón I
Arch Intern Med; 2005 Jul; 165(14):1624-9. PubMed ID: 16043681
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular death in rheumatoid arthritis: a population-based study.
Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
[TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.
Kremers HM; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2004 Nov; 50(11):3450-7. PubMed ID: 15529378
[TBL] [Abstract][Full Text] [Related]
4. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity.
Navarro-Cano G; Del Rincón I; Pogosian S; Roldán JF; Escalante A
Arthritis Rheum; 2003 Sep; 48(9):2425-33. PubMed ID: 13130461
[TBL] [Abstract][Full Text] [Related]
5. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
Capell H; McCarey D; Madhok R; Hampson R
J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
[TBL] [Abstract][Full Text] [Related]
6. Prediction of mortality in rheumatoid arthritis based on disease activity markers.
Book C; Saxne T; Jacobsson LT
J Rheumatol; 2005 Mar; 32(3):430-4. PubMed ID: 15742433
[TBL] [Abstract][Full Text] [Related]
7. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
8. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.
Gabriel SE; Crowson CS; Kremers HM; Doran MF; Turesson C; O'Fallon WM; Matteson EL
Arthritis Rheum; 2003 Jan; 48(1):54-8. PubMed ID: 12528103
[TBL] [Abstract][Full Text] [Related]
9. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
[TBL] [Abstract][Full Text] [Related]
10. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis.
van der Helm-van Mil AH; van der Kooij SM; Allaart CF; Toes RE; Huizinga TW
Ann Rheum Dis; 2008 Jun; 67(6):769-74. PubMed ID: 17965124
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and poststroke mortality.
Olsen TS; Dehlendorff C; Petersen HG; Andersen KK
Neuroepidemiology; 2008; 30(2):93-100. PubMed ID: 18309248
[TBL] [Abstract][Full Text] [Related]
12. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
Reeves KW; Faulkner K; Modugno F; Hillier TA; Bauer DC; Ensrud KE; Cauley JA;
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1468-73. PubMed ID: 17627012
[TBL] [Abstract][Full Text] [Related]
13. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis.
Jacobsson LT; Turesson C; Nilsson JA; Petersson IF; Lindqvist E; Saxne T; Geborek P
Ann Rheum Dis; 2007 May; 66(5):670-5. PubMed ID: 17158824
[TBL] [Abstract][Full Text] [Related]
14. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis.
Van Doornum S; Brand C; King B; Sundararajan V
Arthritis Rheum; 2006 Jul; 54(7):2061-8. PubMed ID: 16802340
[TBL] [Abstract][Full Text] [Related]
15. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis.
Ang DC; Choi H; Kroenke K; Wolfe F
J Rheumatol; 2005 Jun; 32(6):1013-9. PubMed ID: 15940760
[TBL] [Abstract][Full Text] [Related]
16. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.
Kalantar-Zadeh K; Kopple JD; Kilpatrick RD; McAllister CJ; Shinaberger CS; Gjertson DW; Greenland S
Am J Kidney Dis; 2005 Sep; 46(3):489-500. PubMed ID: 16129211
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.
Turesson C; O'Fallon WM; Crowson CS; Gabriel SE; Matteson EL
J Rheumatol; 2002 Jan; 29(1):62-7. PubMed ID: 11824973
[TBL] [Abstract][Full Text] [Related]
18. The widening mortality gap between rheumatoid arthritis patients and the general population.
Gonzalez A; Maradit Kremers H; Crowson CS; Nicola PJ; Davis JM; Therneau TM; Roger VL; Gabriel SE
Arthritis Rheum; 2007 Nov; 56(11):3583-7. PubMed ID: 17968923
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis.
Lopez-Olivo MA; Gonzalez-Lopez L; Garcia-Gonzalez A; Villa-Manzano AI; Cota-Sanchez AR; Salazar-Paramo M; Varon-Villalpando E; Cardona-Muñoz EG; Gamez-Nava JI
Scand J Rheumatol; 2006; 35(2):112-6. PubMed ID: 16641044
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis.
Kovesdy CP; Anderson JE; Kalantar-Zadeh K
Am J Kidney Dis; 2007 May; 49(5):581-91. PubMed ID: 17472839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]